Clinical Trial of AGB101 for Mild Cognitive Impairment

Clinical trial NCT05986721 · WITHDRAWN

Trial details

NCT number: NCT05986721
Sponsor: AgeneBio
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Mild Cognitive Impairment Prodromal Alzheimer's Disease

Start date: 2024-12-03
Primary completion: 2028-07-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.